| Detected | Trial | Change |
|---|---|---|
| 2026-07-28 | NCT07635563 DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation… |
Recruitment opened |
| 2026-07-28 | NCT06146101 RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA |
Trial completed |
| 2026-07-28 | NCT06146101 RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA |
Enrollment reduced: 560 -> 121 participants |
| 2026-07-28 | NCT06146101 RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA |
date change Primary completion moved earlier: 2026-12 -> 2025-05-20 |
| 2026-07-28 | NCT06146101 RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA |
date change Completion moved earlier: 2026-12 -> 2025-07-27 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07635563 | DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation… | Obstructive Sleep Apnea (OSA) | Recruiting |